About Tesio
Tesio is Developing the Next Generation of Anti-inflammatory Products with Kinase Inhibition and State-of-the-art Targeted Drug Delivery
New technology to target the master checkpoint common to all inflammatory pathways and outperform conventional therapeutics
Targeted long-acting local administration provides relief without systemic exposure or steroid side-effects
Lead indications are Lung Fibrosis and Osteoarthritis, the nation’s most common cause of disability